Latest news articles

Added 4 months ago Drug news

Complete Response Letter for Zimhi high dose naloxone to treat opioid overdose.-Adamis Pharma

Adamis Pharmaceuticals Corporation announced that after the close of U.S. markets on November 22nd, it received a Complete Response Letter...

Added 4 months ago Drug news

Adamis statement on PDUFA date for Zimhi.

Adamis Pharmaceuticals Corporation announced that as of the close of business today, Adamis has not received any notice of action...

Added 9 months ago Drug news

European Commission has approved Sixmo for treatment of opioid dependence

Titan Pharmaceuticals, Inc. has announced that the European Commission ("EC") has approved Sixmo-buprenorphine, the brand name for Probuphine (buprenorphine) implant...

Search all news articles for Poisoning by other medications and drugs

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

ESICM LIVES Highlights

ESICM LIVES Highlights

ESICM LIVES Congress 2018: Bringing you the latest news and insights from the 31st ESICM LIVES Congress, 20–24 October 2018 Paris, France.

Fibrinogen Deficiency in Bleeding

Fibrinogen Deficiency in Bleeding

Fibrinogen is important for blood clot formation and breakdown. It is the first coagulant factor to be reduced to critical levels during massive trauma, cardiac surgery and postpartum haemorrhage that involve excessive bleeding. Persistent fibrinogen deficiency can lead to bleeding complications and an increased risk in mortality. This learning zone looks at both congenital and acquired fibrinogen deficiencies including indications and techniques for diagnosis, trigger level for treatment and treatment options.

Load more


Management of Oral and Gastrointestinal Mucosal Injury: ESMO Clinical Practice Guidelines

ESMO Clinical Practice Guidelines for management of oral and gastrointestinal mucositis includes chapters on the definition of mucositis, its incidence and associated complications, risk factors...

Added 4 years ago

Search all guidelines for Poisoning by other medications and drugs

Journal articles

Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy.

Introduction: Five NK-1 RA formulations are commercially available to treat the delayed phase of chemotherapy-induced nausea and vomiting (CINV) occurring between days 2–5 post chemotherapy...

Added 2 years ago

Aprepitant and fosaprepitant drug interactions: a systematic review.

Aims: Aprepitant and fosaprepitant, commonly used for the prevention of chemotherapy-induced nausea and vomiting, alter cytochrome P450 activity. This systematic review evaluates...

Added 2 years ago

Rolapitant for the prevention of delayed nausea and vomiting over initial and repeat courses of emetogenic chemotherapy.

Introduction: Chemotherapy-induced nausea and vomiting (CINV) is a debilitating side effect of many cytotoxic chemotherapy regimens. Although sustained antiemetic control across repeated chemotherapy cycles ...

Added 2 years ago

Search all journal articles for Poisoning by other medications and drugs


Survival guide: safe prescribing for surgical inpatients

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
Registration required
Subscription fee
Search all CME for Poisoning by other medications and drugs